Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-25 @ 2:38 AM
NCT ID:
NCT06613334
Eligibility Criteria:
Inclusion Criteria:
* Affiliated to a social security or other social protection scheme
* Diagnosed with schizophrenia according to the DSM-5 (code F20)
* Stable state without duration criteria
* Main treatment with risperidone or paliperidone, aripiprazole, olanzapine in oral or long-acting injectable form
* Complementary treatment with an antipsychotic for anxiolytic or sedative purposes: chlorpromazine, loxapine or cyamemazine
* Able to speak and read French
* Able to perform speech evaluations
* Able to answer questionnaires on smartphone
* May be under curatorship or guardianship
* Agreeing to participate in the study and with informed consent signed by the subject, as well as by the legal representative in the case of a person under curatorship or guardianship
Exclusion Criteria:
* Suffering from a pathology that impairs French
* Suffering from a neurological pathology: multiple sclerosis, Parkinson's disease, Huntington's disease or neurodegenerative disease
* Treatment with lithium salts
* Anti-epileptic treatment
* Participant in another study involving medication
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT06613334
Study Brief:
Protocol Section:
NCT06613334